Literature DB >> 33710777

Exercise-induced peptide EIP-22 protect myocardial from ischaemia/reperfusion injury via activating JAK2/STAT3 signalling pathway.

Li Zhang1,2, Xuejun Wang2, Hao Zhang3, Mengwen Feng2, Jingjing Ding4, Bing Zhang5, Zijie Cheng2, Lingmei Qian1,2.   

Abstract

Recent studies have revealed that exercise has myocardial protective effects, but the exact mechanism remains unclear. Studies have increasingly found that peptides play a protective role in myocardial ischaemia-reperfusion (I/R) injury. However, little is known about the role of exercise-induced peptides in myocardial I/R injury. To elucidate the effect of exercise-induced peptide EIP-22 in myocardial I/R injury, we first determined the effect of EIP-22 on hypoxia/reperfusion (H/R)- or H2 O2 -induced injury via assessing cell viability and lactate dehydrogenase (LDH) level. In addition, reactive oxygen species (ROS) accumulation and mitochondrial membrane potential (MMP) was assessed by fluorescence microscope. Meanwhile, Western blot and TUNEL methods were used to detect apoptosis level. Then, we conducted mice I/R injury model and verified the effect of EIP-22 by measuring cardiac function, evaluating heart pathology and detecting serum LDH, CK-MB and cTnI level. Finally, the main signalling pathway was analysed by RNA-seq. In vitro, EIP-22 treatment significantly improved cells viabilities and MMP and attenuated the LDH, ROS and apoptosis level. In vivo, EIP-22 distinctly improved cardiac function, ameliorated myocardial infarction area and fibrosis and decreased serum LDH, CK-MB and cTnI level. Mechanistically, JAK/STAT signalling pathway was focussed by RNA-seq and we confirmed that EIP-22 up-regulated the expression of p-JAK2 and p-STAT3. Moreover, AG490, a selective inhibitor of JAK2/STAT3, eliminated the protective roles of EIP-22. The results uncovered that exercise-induced peptide EIP-22 protected cardiomyocytes from myocardial I/R injury via activating JAK2/STAT3 signalling pathway and might be a new candidate molecule for the treatment of myocardial I/R injury.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Entities:  

Keywords:  EIP-22; JAK2/STAT3; myocardial I/R; peptide

Year:  2021        PMID: 33710777     DOI: 10.1111/jcmm.16441

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  4 in total

1.  Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways.

Authors:  Na Dong; Pan-Pan Zhou; Dong Li; Hua-Su Zhu; Ling-Hong Liu; Hui-Xian Ma; Qing Shi; Xiu-Li Ju
Journal:  World J Stem Cells       Date:  2022-07-26       Impact factor: 5.247

Review 2.  Exercise-induced signaling pathways to counteracting cardiac apoptotic processes.

Authors:  Hamed Alizadeh Pahlavani
Journal:  Front Cell Dev Biol       Date:  2022-08-11

3.  miRNA-146a Mimic Inhibits NOX4/P38 Signalling to Ameliorate Mouse Myocardial Ischaemia Reperfusion (I/R) Injury.

Authors:  Lili Xiao; Yulei Gu; Gaofei Ren; Linlin Chen; Liming Liu; Xiaofang Wang; Lu Gao
Journal:  Oxid Med Cell Longev       Date:  2021-07-27       Impact factor: 6.543

4.  Effects of different intensities of continuous training on vascular inflammation and oxidative stress in spontaneously hypertensive rats.

Authors:  Minghao Luo; Chunmei Cao; Josef Niebauer; Jianghong Yan; Xindong Ma; Qing Chang; Ting Zhang; Xiaoxiao Huang; Guochun Liu
Journal:  J Cell Mol Med       Date:  2021-07-31       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.